Tissue Regenix Group PLC (LSE:TRX) - Share price


Stock Report

Tissue Regenix Group PLC TRX

Balance Sheet
20152016201720182019
Fiscal Year Ends31/01/201531/01/201631/12/201731/12/201831/12/2019
Assets
Non Current Assets
Intangible-0.0019.3119.9418.00
Tangible0.440.902.992.832.36
Investments-----
Other-----
Total0.440.9022.3022.7720.36
Current Assets
Stock0.030.062.872.334.19
Debtors1.952.332.503.552.54
Cash and Securities10.2619.9116.427.822.38
Total12.2422.3023.4614.9010.14
Held for Disposal-----
Total Assets12.6723.2045.7637.6630.50
Liabilities and Equity
Liabilities
Current1.101.964.784.303.12
Non-Current-----
Total-----
Equity
Share Capital35.2454.2692.2592.2692.26
Reserves-23.64-33.06-52.68-59.50-67.20
Shareholders Funds11.5821.3239.9333.0525.21
Minorities0.00-0.08-0.41-0.48-0.62
Total11.5821.2439.5232.5724.60
Total Liabilities and Equity12.6723.2045.7637.6630.50
Net Borrowings-10.26-19.91-16.42-7.82-0.09
Investment Ratios
Net Tangible Asset Val PS2.393.550.581.430.81
ROCE-72.28-48.22-26.28-25.83-26.23
ROE-49.62-57.20-35.69-22.43-23.94
Gross Gearing0.000.000.000.009.07
Cash88.5993.3641.1323.659.44
Interest Cover x0.000.000.00-32.89-15.06
Quick Ratio r11.1511.353.962.641.58
Current Ratio r11.1811.394.913.463.26
Borrowings
Total Borrowings----2.29
Due < 1 Yr----0.17
Due 1-2 Yrs-----
Due 2-5 Yrs----2.12
Due > 5 Yrs-----

GBP in Millions except per share data.

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.